RKL Wealth Management LLC Sells 432 Shares of Danaher Co. (NYSE:DHR)

RKL Wealth Management LLC decreased its stake in shares of Danaher Co. (NYSE:DHR) by 9.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,067 shares of the conglomerate’s stock after selling 432 shares during the quarter. RKL Wealth Management LLC’s holdings in Danaher were worth $934,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Machina Capital S.A.S. boosted its position in shares of Danaher by 455.4% during the fourth quarter. Machina Capital S.A.S. now owns 10,552 shares of the conglomerate’s stock worth $2,422,000 after acquiring an additional 8,652 shares during the last quarter. Mesirow Financial Investment Management Inc. lifted its position in Danaher by 3.3% during the fourth quarter. Mesirow Financial Investment Management Inc. now owns 15,171 shares of the conglomerate’s stock valued at $3,481,000 after purchasing an additional 490 shares during the last quarter. Berkshire Asset Management LLC PA lifted its position in Danaher by 4.5% during the fourth quarter. Berkshire Asset Management LLC PA now owns 1,300 shares of the conglomerate’s stock valued at $320,000 after purchasing an additional 56 shares during the last quarter. EFG Asset Management Americas Corp. lifted its position in Danaher by 7.5% during the fourth quarter. EFG Asset Management Americas Corp. now owns 31,889 shares of the conglomerate’s stock valued at $7,320,000 after purchasing an additional 2,230 shares during the last quarter. Finally, Bradyco Inc. bought a new position in Danaher during the fourth quarter valued at $299,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 1.1 %

DHR stock opened at $212.35 on Friday. The company has a market capitalization of $151.77 billion, a PE ratio of 40.22, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The firm’s 50-day moving average is $222.51 and its 200 day moving average is $243.02. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm posted $2.09 EPS. On average, research analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. Danaher’s dividend payout ratio (DPR) is 24.24%.

Analyst Ratings Changes

Several research firms have commented on DHR. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Jefferies Financial Group lowered their price objective on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Finally, Citigroup lowered their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.